ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,170Medicare Part D Prescriptions Filled, Including Refills

Rank: 821 out of 2061

$401K Total Retail Price of All Prescriptions

Rank: 906 out of 2061

648 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 648 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 648 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 5,590 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 339 282 1 1
LEVOTHYROXINE SODIUM 243 226 2 3
AMLODIPINE BESYLATE 228 188 3 4
METFORMIN HCL 221 178 4 9
GABAPENTIN 196 146 5 15
METOPROLOL SUCCINATE 182 153 6 19
OMEPRAZOLE 176 118 7 5
LISINOPRIL 175 152 8 2
FUROSEMIDE 160 139 9 6
LOSARTAN POTASSIUM 151 138 10 17
METOPROLOL TARTRATE 139 128 11 7
HYDROCODONE-ACETAMINOPHEN 129 84 S3 12 10
TRAMADOL HCL 120 67 13 18
ZOLPIDEM TARTRATE 115 97 14 23
HYDROCHLOROTHIAZIDE 112 107 15 12
PRAVASTATIN SODIUM 89 70 16 14
GLIMEPIRIDE 88 81 17 33
DICLOFENAC SODIUM 87 70 18 147
PROAIR HFA 74 57 19 40
ATENOLOL 71 63 20 13
TRIAMTERENE-HCTZ 71 66 20 38
AMLODIPINE BESYLATE-BENAZEPRIL 70 55 22 79
ATORVASTATIN CALCIUM 66 50 23 8
SERTRALINE HCL 63 46 24 21
NEXIUM 59 38 25 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 53 26 27
MELOXICAM 58 40 26 44
DIGOXIN 57 57 28 56
DONEPEZIL HCL 57 56 28 24
POTASSIUM CHLORIDE 57 50 28 16
AZITHROMYCIN 54 43 31 34
ENALAPRIL MALEATE 54 46 31 75
TAMSULOSIN HCL 53 53 33 30
LANTUS 51 43 34 48
ALENDRONATE SODIUM 51 50 34 25
SPIRIVA 50 40 36 63
CYMBALTA 50 41 36 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 8, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.